Treatment of Parkinson’s disease with pergolide and relation to restrictive valvular heart disease
G Van Camp, A Flamez, B Cosyns, C Weytjens, L Muyldermans, M Van Zandjicke, J De Sutter, P Santens, P Decoodt, C Moerman, D Schoors
Lancet 2004;363:1179-1183

Use of pergolide may be associated with a high risk for restrictive valvular heart disease, according to this study. Previous studies of this phenomenon have indicated relatively low rates of valvular heart disease.

WE MOVE looks forward to seeing you at the Annual Meeting of the American Academy of Neurology. We will also be representing The Tourette Syndrome Association and Parents of Infants and Children with Kernicterus (PICK).